Tumor Markers
Tumor Marker: a biomarker found in the body system that can be elevated by the presence of all types of cancer. Each tumor marker is indicative of a particular disease process, and are used in oncology to help detect the presence of cancer.
MAR 24, 2021
7:00 AM PDT
MAR 24, 2021
7:00 AM PDT
Date: March 24, 2021 Time: 7:00am (PST), 10:00am (EST), 3:00pm (CET) Multiplex immunofluorescence IHC is a powerful technique to address the increasing research needs in immuno-oncology t...
MAR 09, 2021
8:00 AM PST
MAR 09, 2021
8:00 AM PST
Date: March 09, 2021 Time: 8:00am (PST), 11:00am (EST) Lung cancer is one of the three most common types of cancer. Representing 85% of all lung cancers...
JAN 28, 2021
7:00 AM PST
C.E. CREDITS
JAN 28, 2021
7:00 AM PST
Date: January 28, 2021 Time: 7:00am (PST), 10:00am (EST) Many of the newly recognized clinically significant genetic markers in pediatric leukemias cannot be reliably detected by routine dia...
NOV 13, 2020
4:00 PM PST
NOV 13, 2020
4:00 PM PST
Three-dimensional (3D) cell culture spheroids and aggregates are preferred over monolayer cell culture due to their architectural and functional similarity to solid tumors. To study expressi...
NOV 12, 2020
9:00 AM PST
NOV 12, 2020
9:00 AM PST
Three-dimensional (3D) cell culture spheroids and aggregates are preferred over monolayer cell culture due to their architectural and functional similarity to solid tumors. To study expressi...
NOV 12, 2020
C.E. CREDITS
NOV 12, 2020
Cancer cells can acquire immune resistance resulting in a loss of immunosurveillance. Tumor cells can upregulate PDL-1 which binds to PD-1. This complex inhibits CD8 Tumor Infiltrating cells...
C.E. CREDITS
Dr. Bacher will be discussing the history and evolution of MSI, the differences between popular testing methods, and what the future holds for this powerful biomarker....
OCT 08, 2020
10:00 AM PDT
C.E. CREDITS
OCT 08, 2020
10:00 AM PDT
DATE: October 8, 2020 TIME: 1:00pm PDT Microsatellite instability (MSI) has evolved as a marker of potential hereditary cancer risk and is now a tissue agnostic immune biomarker with a broad...
SEP 15, 2020
8:00 AM PDT
C.E. CREDITS
SEP 15, 2020
8:00 AM PDT
DATE: September 15, 2020 TIME: 08:00am PT Tumorigenesis and cancer progression are affected by the tumor immune microenvironment (TIME). The TIME not only influences the efficiency of existi...
JUN 30, 2020
9:00 AM PDT
C.E. CREDITS
JUN 30, 2020
9:00 AM PDT
DATE: June 30, 2020 TIME: 9:00am PDT, 12:00pm EDT QC laboratories perform a critical role in demonstrating pharmaceutical products are consistently manufactured, safe, potent, and pure. At t...
JUN 30, 2020
8:00 AM PDT
C.E. CREDITS
JUN 30, 2020
8:00 AM PDT
DATE: June 30, 2020 TIME: 8:00am PT, 11:00am Understanding the tumor microenvironment (TME) is essential for the development of effective treatments for cancer patients. Traditional multi...
JUN 17, 2020
1:30 PM PDT
C.E. CREDITS
JUN 17, 2020
1:30 PM PDT
Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
JUN 16, 2020
10:30 AM PDT
JUN 03, 2020
4:00 PM PDT
C.E. CREDITS
JUN 03, 2020
4:00 PM PDT
The RNAscope in situ hybridization technology allows high sensitivity, specificity and spatial resolution providing pivotal single-cell gene expression information to gain better insights in...
JUN 03, 2020
12:00 PM PDT
C.E. CREDITS
JUN 03, 2020
12:00 PM PDT
A key step in the clinical production of CAR T cells is the expansion of engineered T cells. To generate enough cells for viable adoptive cell therapy, cells must be robustly stimulated, whi...
